These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 22105817

  • 21. Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial.
    Loehrer PJ, Wang W, Johnson DH, Aisner SC, Ettinger DS, Eastern Cooperative Oncology Group Phase II Trial.
    J Clin Oncol; 2004 Jan 15; 22(2):293-9. PubMed ID: 14722038
    [Abstract] [Full Text] [Related]

  • 22. Treatment of advanced thymoma and thymic carcinoma.
    Rajan A, Giaccone G.
    Curr Treat Options Oncol; 2008 Dec 15; 9(4-6):277-87. PubMed ID: 19381821
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Pemetrexed in patients with thymic malignancies previously treated with chemotherapy.
    Liang Y, Padda SK, Riess JW, West RB, Neal JW, Wakelee HA.
    Lung Cancer; 2015 Jan 15; 87(1):34-8. PubMed ID: 25443273
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Therapeutic options in thymomas and thymic carcinomas.
    Muto Y, Okuma Y.
    Expert Rev Anticancer Ther; 2022 Apr 15; 22(4):401-413. PubMed ID: 35266421
    [Abstract] [Full Text] [Related]

  • 29. Mutational status of EGFR and KIT in thymoma and thymic carcinoma.
    Yoh K, Nishiwaki Y, Ishii G, Goto K, Kubota K, Ohmatsu H, Niho S, Nagai K, Saijo N.
    Lung Cancer; 2008 Dec 15; 62(3):316-20. PubMed ID: 18448188
    [Abstract] [Full Text] [Related]

  • 30. [Chemotherapy for thymic carcinoma].
    Okuma Y.
    Gan To Kagaku Ryoho; 2012 May 15; 39(5):702-7. PubMed ID: 22584319
    [Abstract] [Full Text] [Related]

  • 31. Thymic neoplasms: an update on the use of chemotherapy and new targeted therapies. A literature review.
    Berardi R, De Lisa M, Pagliaretta S, Onofri A, Morgese F, Savini A, Ballatore Z, Caramanti M, Santoni M, Mazzanti P, Cascinu S.
    Cancer Treat Rev; 2014 May 15; 40(4):495-506. PubMed ID: 24355362
    [Abstract] [Full Text] [Related]

  • 32. Thymoma versus thymic carcinoma: differences in biology impacting treatment.
    Kelly RJ.
    J Natl Compr Canc Netw; 2013 May 01; 11(5):577-83. PubMed ID: 23667207
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. When a thymic carcinoma "becomes" a GIST.
    Rossi V, Donini M, Sergio P, Passalacqua R, Rossi G, Buti S.
    Lung Cancer; 2013 Apr 01; 80(1):106-8. PubMed ID: 23375402
    [Abstract] [Full Text] [Related]

  • 35. [Thymoma and somatostatin analogs. Biology, diagnostic and clinical practice].
    Palmieri G, Montella L, Lastoria S.
    Minerva Endocrinol; 2001 Sep 01; 26(3):193-5. PubMed ID: 11753243
    [Abstract] [Full Text] [Related]

  • 36. Efficacy and toxicities of gemcitabine and cisplatin combined with endostar in advanced thymoma and thymic carcinoma.
    Wang Y, Nie J, Dai L, Hu W, Chen X, Han J, Ma X, Tian G, Han S, Long J, Zhang Z, Fang J.
    Thorac Cancer; 2019 Jan 01; 10(1):17-23. PubMed ID: 30411854
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Long lasting response to the multikinase inhibitor bay 43-9006 (Sorafenib) in a heavily pretreated metastatic thymic carcinoma.
    Bisagni G, Rossi G, Cavazza A, Sartori G, Gardini G, Boni C.
    J Thorac Oncol; 2009 Jun 01; 4(6):773-5. PubMed ID: 19461405
    [Abstract] [Full Text] [Related]

  • 39. RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma.
    Imbimbo M, Vitali M, Fabbri A, Ottaviano M, Pasello G, Petrini I, Palmieri G, Berardi R, Zucali P, Ganzinelli M, Marabese M, Broggini M, Marino M, Trama A, Rulli E, Hollander L, Pruneri G, Torri V, Garassino MC.
    Clin Lung Cancer; 2018 Sep 01; 19(5):e811-e814. PubMed ID: 30033090
    [Abstract] [Full Text] [Related]

  • 40. Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experience.
    Ströbel P, Bargou R, Wolff A, Spitzer D, Manegold C, Dimitrakopoulou-Strauss A, Strauss L, Sauer C, Mayer F, Hohenberger P, Marx A.
    Br J Cancer; 2010 Jul 13; 103(2):196-200. PubMed ID: 20571495
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.